SCHEMBL22449442

SCHEMBL22449442

COc1ccc(-c2ccn3c(c2)cc2c4ccccc4nc(-c4ccc(OC)cc4)c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ADORA2A P29274 1/20 0.47
▸ MAPT P10636 4/20 0.44
▸ ACACA Q13085 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ KMT2A Q03164 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ CYP1A2 P05177 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TNK2 Q07912 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22449468 0.94 ALDH1A1 (0.47) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449443 0.93 RAD51 (0.48) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449458 0.93 KMT2A (0.47) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449451 0.92 ACP1 (0.48) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449441 0.90 TP53 (0.44) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449469 0.89 KDM4E (0.48) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449460 0.88 KMT2A (0.42) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL17620548 0.88 KDM4E (0.52) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449477 0.86 KMT2A (0.49) LMNAALDH1A1KDM4ENPSR1TDP1
SCHEMBL22449470 0.86 ACP1 (0.46) LMNAALDH1A1KDM4ENPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2020-09-29 — — US claimed
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2020-09-29 — — US disclosed
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2020-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe DNA2, IRF3, DDB1 LMNA 155/4885ALDH1A1 4405/4885KDM4E 4624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback